5Jemal A, Siegel R, Ward E, et al. Cancer statistics [J]. Cancer Clin ,2007,57:43 - 66.
6American Society of clinical oncology. Clinical practice guidelines for the treatment of unresecable non - small cell lung cancer[ J]. Clin Oncol, 1997,15:2996 - 3018.
7Sause WT,Scott C ,Taylor S,et al. Radiation Therapy Oncology Group (RTOG) 88208 and Eastern Cooperative Oncology Group(ECOG) 4588 : preliminary results of a phase Ⅲ trial in regionally advanced, urtresect2 able non - small - cell lung cancer[ J ]. Natl Cancer Inst, 1995,87 (3) : 198 - 205.
8Le Chevalier T, Arriagada R, Tarayre M, et al. Significant effect of ad2 juvant chemotherapy on survival in locally advanced non2small2cell lung carcinoma ( letter ) [ J ]. Natl Cancer Inst, 1992,84( 1 ) :58.
9Sculier JP,Paesmans M ,Lafitte J,et al. A randomised phase Ⅲ trial comparing consolidation treatment with further chemotherapyto chest irradiation in patients with initially unresectable locoregional non - small - cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party [ J]. Ann Oncol. 1999,10:295.
10Furuse K, Fukuoka M, kawahara M,et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycine vindesin and cisplatin in unresectable stage Ⅲ non - small cell lung cancer[ J ]. Clin Oncol, 1999,17:2692 - 2699.
